Marta Córdoba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marta Córdoba has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Dolores González-Morón
Neurogenetics Unit, Hospital JM Ramos Mejia, Buenos Aires, Argentina
2 shared publications - Marcelo Andres Kauffman
Neurogenetics Unit, Hospital JM Ramos Mejia-Conicet, General Urquiza 609, Buenos Aires, Argentina
2 shared publications Ana Lía Taratuto
1 shared publication- Cecilia Vazquez-Dusefante
Consultorio y Laboratorio de Neurogenetica. Hospital JM Ramos Mejia. IBCN UBA-CONICET
1 shared publication - Damián E. Consalvo
University of Buenos Aires
1 shared publication - Julieta Rosales
Hospital Jose Maria Ramos Mejia
1 shared publication
Latest Publications
- 1 October 2017
- Published by Elsevier in Neurología Argentina
- Vol. 9 (4) , 231-242
Diagnóstico de las enfermedades mitocondriales: utilidad de un abordaje clínico-molecular sistematizado incorporando secuenciación de alto rendimiento
- 1 October 2017
- Published by Elsevier in Neurología Argentina
- Vol. 9 (4) , 231-242
Diagnóstico de las enfermedades mitocondriales: utilidad de un abordaje clínico-molecular sistematizado incorporando secuenciación de alto rendimiento
- 14 October 2012
- Published by Springer Nature in Molecular Biology Reports
- Vol. 39 (12) , 10615-10619
SLC6A4 gene variants and temporal lobe epilepsy susceptibility: a meta-analysis
There seems to be a role for serotoninergic neuro-transmission in the pathophysiology of the epilepsies. Different groups have studied the role of regulatory variants in the SLC6A4 gene, which code for the central serotonin transporter, in the complex genetics of temporal lobe epilepsy (TLE) obtaining contradictory findings. Therefore, a systematic review and critical analysis of this topic seem to be timely. Published studies up to October 2011 of TLE and the SLC6A4 promoter and intron 2 variant number repeat polymorphisms (VNTR) were identified by searches of Medline, Scopus and ISI-Web of Sciences databases. Meta-analysis of TLE case-control data were performed to assess the association of SLC6A4 VNTRs with TLE susceptibility. Pooled odds ratios were estimated by means of a genetic-model-free approach. The quality of the included studies was assessed by a score. The studies included compared a total of 991 TLE cases and 1,202 controls. We did not find synthetic evidence of association between SLC6A4 promoter and intron 2 variants and the risk of TLE. However, the intron 2 VNTR seems to have opposite effects in different populations. In this meta-analysis our findings were inconclusive in order to associate any of the 5-HT receptor gene variants with the risk of TLE.
- 14 October 2012
- Published by Springer Nature in Molecular Biology Reports
- Vol. 39 (12) , 10615-10619
SLC6A4 gene variants and temporal lobe epilepsy susceptibility: a meta-analysis
There seems to be a role for serotoninergic neuro-transmission in the pathophysiology of the epilepsies. Different groups have studied the role of regulatory variants in the SLC6A4 gene, which code for the central serotonin transporter, in the complex genetics of temporal lobe epilepsy (TLE) obtaining contradictory findings. Therefore, a systematic review and critical analysis of this topic seem to be timely. Published studies up to October 2011 of TLE and the SLC6A4 promoter and intron 2 variant number repeat polymorphisms (VNTR) were identified by searches of Medline, Scopus and ISI-Web of Sciences databases. Meta-analysis of TLE case-control data were performed to assess the association of SLC6A4 VNTRs with TLE susceptibility. Pooled odds ratios were estimated by means of a genetic-model-free approach. The quality of the included studies was assessed by a score. The studies included compared a total of 991 TLE cases and 1,202 controls. We did not find synthetic evidence of association between SLC6A4 promoter and intron 2 variants and the risk of TLE. However, the intron 2 VNTR seems to have opposite effects in different populations. In this meta-analysis our findings were inconclusive in order to associate any of the 5-HT receptor gene variants with the risk of TLE.